Streetbeat News

Analyst Ratings

APLS

HC Wainwright & Co. analyst Douglas Tsao has reiterated a 'Buy' rating on Apellis Pharmaceuticals (NASDAQ:APLS) and maintained a price target of $82.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 10:34 am

EXEL

HC Wainwright & Co. analyst Robert Burns has initiated coverage on Exelixis (NASDAQ:EXEL) with a Buy rating and a price target of $28.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 10:32 am

VERA

HC Wainwright & Co. analyst Ed Arce maintains a 'Buy' rating on Vera Therapeutics and raises the price target from $10 to $25.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 10:28 am

CING

HC Wainwright & Co. analyst Raghuram Selvaraju maintains a Buy rating on Cingulate (NASDAQ:CING) but lowers the price target from $5.5 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 10:27 am

PERI

Needham analyst Laura Martin has reiterated a Buy rating on Perion Network (NASDAQ:PERI) and maintained a $42 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 10:24 am

ADTH

Needham analyst Laura Martin has reiterated a 'Buy' rating on AdTheorent Holding (NASDAQ:ADTH) and maintained a price target of $3.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 10:22 am

OB

Needham analyst Laura Martin has reiterated a 'Buy' rating on Outbrain (NASDAQ:OB) and maintained a price target of $6.5.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 10:20 am

PPTA

HC Wainwright & Co. analyst Heiko Ihle maintains a 'Buy' rating on Perpetua Resources (NASDAQ:PPTA) but lowers the price target from $10.25 to $10.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 10:18 am

CHRS

HC Wainwright & Co. analyst Douglas Tsao has reiterated a 'Buy' rating on Coherus BioSciences (NASDAQ:CHRS) and maintained a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 10:16 am

DAL

Bernstein analyst David Vernon has maintained an 'Outperform' rating on Delta Air Lines (NYSE:DAL) but lowered the price target from $62 to $61.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 9:39 am